ASCO 2022: Crenolanib Combined With Chemotherapy in Newly Diagnosed FLT3-Mutant AML

Posted: 06/27/2022 | By: Melissa E. Fryman, MS

Question 1 of 5

In a study population of newly diagnosed adult patients with acute myeloid leukemia (AML), besides FLT3-ITD, which of the following mutations was most prevalent?

Choose 1